** Shares of EMVision Medical Devices rise as much as 17.7% to A$2.1, their best trading session since early March
** Shares hit their highest level since Oct. 22
** Medical equipment and tech co reports successful results from its neurodiagnostic technology for early identification of stroke and stroke types
** Says study highlights sensing capabilities, including successful detection and classification of very small haemorrhages
** Adds AI-based diagnostic models demonstrated improved performance as additional clinical data was provided
** More than 78,000 shares change hands vs 30-day avg volume of around 35,000 shares
** YTD, EMV up 21.5% as of 0100 GMT
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.